New Penn-Designed Gel Allows for Targeted Therapy After Heart Attack

Combatting the tissue degrading enzymes that cause lasting damage following a heart attack is tricky. Each patient responds to a heart attack differently and damage can vary from one part of the heart muscle to another, but existing treatments can’t be fine-tuned to deal with this variation. 

Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction

Targeting and arginine-driven synergizing photodynamic therapy with nutritional immunotherapy nanosystems for combating MRSA biofilms

Novel Dual CAR T Cell Immunotherapy Holds Promise for Targeting the HIV Reservoir

Factors Influencing Retention of Injected Biomaterials to Treat Myocardial Infarction - Schotman - 2022 - Advanced Materials Interfaces - Wiley Online Library

Functional Impact of Alternative Metabolic Substrates in Failing Human Cardiomyocytes

Engineering Injectable Anti‐Inflammatory Hydrogels to Treat Acute Myocardial Infarction - Zhang - 2022 - Advanced NanoBiomed Research - Wiley Online Library

Improvement in cardiac function and regional LV strain following intramyocardial injection of a theranostic hydrogel early postmyocardial infarction in a porcine model

Frontiers Recent Advances in Nanomaterials for Diagnosis, Treatments, and Neurorestoration in Ischemic Stroke

tissue engineering – Penn Bioengineering Blog

Targeting and arginine-driven synergizing photodynamic therapy with nutritional immunotherapy nanosystems for combating MRSA biofilms

Sight + Sound, Spring 2022 by Eye & Ear Foundation of Pittsburgh - Issuu

Frontiers Proinflammatory mediators, TNFα, IFNγ, and thrombin, directly induce lymphatic capillary tube regression

Targeting miR-30d reverses pathological cardiac hypertrophy - eBioMedicine

New Penn-Designed Gel Allows for Targeted Therapy After Heart Attack